Reducing Barriers to Accessing Administrative Data on SARS-CoV-2 Vaccination for Research

Matthew Herder, Andrew McRae, Patrick Archambault, Patrick Fok, Hana Wiemer, Laurie Morrison

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Public trust in scientific research, especially research regarding vaccines, has proven fragile during the COVID-19 pandemic. To counter abundant misinformation about SARS-CoV-2 vaccines, rigorous, ongoing evaluations of vaccine safety and effectiveness by independent Canadian researchers are important. However, researchers' efforts to conduct timely, national studies of vaccine effectiveness have been hindered by barriers to data sharing that have made it difficult to integrate patients' vaccination status into SARS-CoV-2 clinical and epidemiological studies. Here, McRae et al discuss how a risk-averse data-sharing culture has led to missed opportunities to conduct robust, timely, pan-Canadian SARS-CoV-2 clinical and vaccine effectiveness studies, and outline mechanisms for data sharing that can and should be undertaken.

    Original languageCanadian English
    JournalArticles, Book Chapters, & Popular Press
    Publication statusPublished - Jan. 1 2022

    Keywords

    • Canadian Government
    • Epidemiology & Epidemiological Methods
    • Health Policy
    • Health Services
    • Infectious Diseases: COVID-19

    Disciplines

    • Health Law and Policy
    • Law
    • Medical Jurisprudence
    • Science and Technology Law

    Fingerprint

    Dive into the research topics of 'Reducing Barriers to Accessing Administrative Data on SARS-CoV-2 Vaccination for Research'. Together they form a unique fingerprint.

    Cite this